These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. Sampliner RE Am J Gastroenterol; 1994 Oct; 89(10):1844-8. PubMed ID: 7942680 [TBL] [Abstract][Full Text] [Related]
44. Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders. Langtry HD; Wilde MI Drugs; 1997 Sep; 54(3):473-500. PubMed ID: 9279507 [TBL] [Abstract][Full Text] [Related]
45. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Sharma P; Sampliner RE; Camargo E Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303 [TBL] [Abstract][Full Text] [Related]
46. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Cooper BT; Chapman W; Neumann CS; Gearty JC Aliment Pharmacol Ther; 2006 Mar; 23(6):727-33. PubMed ID: 16556174 [TBL] [Abstract][Full Text] [Related]
47. [Treatment of Barrett esophagus with argon plasma coagulation with acid suppression--a prospective study]. Martin WR; Jakobs R; Spiethoff A; Maass S; Riemann JF Z Gastroenterol; 1999 Sep; 37(9):779-84. PubMed ID: 10522363 [TBL] [Abstract][Full Text] [Related]
48. Acid control and regression of Barrett's esophagus: is the glass half full or half empty? Castell DO; Katz PO Am J Gastroenterol; 1997 Dec; 92(12):2329-30. PubMed ID: 9399786 [No Abstract] [Full Text] [Related]